{"slug":"tirzepatide-cognition","verification":{"valid":true,"entries":2,"head":"356b6b08fcdb3c06e2695090fd9eef8e0ef72b5f0880e6d3146cd751b202c641"},"energy":{"passes":2,"tokens_in":17264,"tokens_out":3373,"tokens_total":20637,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"356b6b08fcdb3c06e2695090fd9eef8e0ef72b5f0880e6d3146cd751b202c641"},"provenance":[{"ts":"2026-06-29T22:51:02.579Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tirzepatide for Cognition\nSlug: tirzepatide-cognition\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tirzepatide\",\"name\":\"Tirzepatide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tirzepatide\",\"name\":\"Tirzepatide\",\"section_title\":\"Why Tirzepatide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\",\"**What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\",\"**Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n2. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\\n3. **Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition pr","response":"{\n  \"slug\": \"tirzepatide-cognition\",\n  \"title\": \"Tirzepatide for Cognition\",\n  \"body\": \"## What's breaking down\\n\\nCognition depends on stable brain metabolism, insulin signaling, and low inflammation. When these layers degrade faster than repair mechanisms restore them, cognitive issues can persist. Metabolic overload from higher body weight adds compressive forces on the spine and joints—roughly four pounds of lumbar load per extra pound of body weight—which can compound systemic strain and indirectly affect neural pathways through ongoing inflammation or reduced mobility. Tirzepatide is studied primarily for weight loss via GLP-1/GIP agonism, which targets the metabolic load layer rather than directly masking symptoms.\\n\\n## Why Tirzepatide might help you\\n\\n1. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n2. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\\n3. **Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\\n\\nIf excess body weight contributes to your metabolic stress, weight reduction may ease spinal and joint compression, potentially supporting overall repair capacity that includes brain metabolic health.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Tirzepatide** → metabolic load / body weight\\n\\n## What the evidence actually shows\\n\\nHuman data come mainly from observational cohort studies in people with type 2 diabetes and obesity. One large EHR-based analysis of 60,860 patients found semaglutide or tirzepatide users had lower dementia risk (HR 0.63) compared with other antidiabetic drugs (human tier). A retrospective cohort comparing tirzepatide to semaglutide in T2DM reported lower","tokens_in":17264,"tokens_out":3373,"cost":0,"prev":"genesis","hash":"8960e3c02230a13cd84e2d2346fc23f284c045b29f71447a83f24a28b93e3a43"},{"ts":"2026-07-17T02:43:14.890Z","model":"owner","action":"voxel_divide","prompt":"","input":"tirzepatide-cognition","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8960e3c02230a13cd84e2d2346fc23f284c045b29f71447a83f24a28b93e3a43","hash":"356b6b08fcdb3c06e2695090fd9eef8e0ef72b5f0880e6d3146cd751b202c641"}]}